Morocco Recalls Ranitidine Stomach Medications Over Cancer Risk

The withdrawn drugs would contain carcinogenic products. A confidential circular dated September 18 asked all laboratories operating in Morocco to withdraw these drugs from the market, after studies in the United States showed that one of the molecules contained in these drugs can have a carcinogenic effect on humans.

A World Health Organization (WHO) alert had already prompted several countries to withdraw all Ranitidine-containing drugs from their markets.

But if these drugs are dangerous, Le360 is surprised that such information is the subject of a confidential note. We also wonder why the Directorate of Medicines and Pharmacy has called on pharmaceutical laboratories to carry out additional analyses on these drugs themselves, knowing that this would pose a conflict of interest.

This alert will remain in effect until further analyses are carried out by several laboratories, internationally.